share_log

5Needham Reiterates Buy on Bicycle Therapeutics, Maintains $38 Price Target

5Needham Reiterates Buy on Bicycle Therapeutics, Maintains $38 Price Target

Needham重申對Bicycle Therapeutics的買入評級,維持38美元的目標價。
Benzinga ·  08/07 06:39  · 評級/大行評級

Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $38 price target.

Needham分析師Ami Fadia重申買入Bicycle Therapeutics(納斯達克:BCYC),並維持目標價格爲38美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論